GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Glow LifeTech Corp (XCNQ:GLOW) » Definitions » Capex-to-Operating-Cash-Flow

Glow LifeTech (XCNQ:GLOW) Capex-to-Operating-Cash-Flow : 0.00 (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Glow LifeTech Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

Glow LifeTech's Capital Expenditure for the three months ended in Sep. 2023 was C$0.00 Mil. Its Cash Flow from Operations for the three months ended in Sep. 2023 was C$-0.08 Mil.

GuruFocus do not calculate Capex-to-Operating-Cash-Flow if the Cash Flow from Operations is negative.


Glow LifeTech Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for Glow LifeTech's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glow LifeTech Capex-to-Operating-Cash-Flow Chart

Glow LifeTech Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Capex-to-Operating-Cash-Flow
- - - -

Glow LifeTech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Capex-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Glow LifeTech's Capex-to-Operating-Cash-Flow

For the Biotechnology subindustry, Glow LifeTech's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Glow LifeTech's Capex-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Glow LifeTech's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Glow LifeTech's Capex-to-Operating-Cash-Flow falls into.



Glow LifeTech Capex-to-Operating-Cash-Flow Calculation

Glow LifeTech's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Dec. 2022 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-0.062) / -1.295
=N/A

Glow LifeTech's Capex-to-Operating-Cash-Flow for the quarter that ended in Sep. 2023 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (0) / -0.08
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Glow LifeTech  (XCNQ:GLOW) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


Glow LifeTech Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Glow LifeTech's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Glow LifeTech (XCNQ:GLOW) Business Description

Traded in Other Exchanges
Address
65 International Boulevard, Suite 206, Etobicoke, ON, CAN, M9W 6L9
Glow LifeTech Corp is a biotechnology company focused on producing nutraceutical and cannabinoid-based products with dramatically enhanced bioavailability, absorption, and effectiveness. Its plant-based MyCell Technology delivery system transforms poorly absorbed natural compounds into enhanced water-compatible concentrates, unlocking the full healing potential of natural active compounds.
Executives
Daniel Proska Director

Glow LifeTech (XCNQ:GLOW) Headlines

No Headlines